\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ examination\\ and\\ laboratory\\ data\\ were\\ noncontributory\ \(0\)\
\-\ complete\\ resection\\ is\\ often\\ curative\\,\\ but\\ will\\ recur\\ if\\ incomplete\\.\\ \\ chemotherapy\\ is\\ used\\ in\\ cases\\ of\\ recurrence\\.\ \(0\)\
\-\ diffuse\\ encephalomalacic\\ changes\\ are\\ seen\\ in\\ the\\ right\\ cerebellum\\ secondary\\ to\\ a\\ right\\ suboccipital\\ craniectomy\\.\\ \\ a\\ heterogeneous\\ cystic\\ and\\ solid\\ lesion\\ is\\ seen\\ at\\ the\\ right\\ cerebellopontine\\ angle\\ with\\ heterogeneous\\ contrast\\ enhancement\\ of\\ a\\ mural\\ nodule\\.\ \(0\)\
\-\ juvenile\\ pilocytic\\ astrocytoma\ \(4\)\
\-\ pilocytic\\ astrocytoma\ \(31\)\
\-\ medulloblastoma\\ \ \(8\)\
\-\ hemangioblastoma\ \(37\)\
\-\ ependymoma\ \(74\)\
\-\ this\\ patient\\ originally\\ presented\\ at\\ the\\ age\\ of\\ 3\\ with\\ right\\ facial\\ palsy\\,\\ worsening\\ over\\ a\\ six\\ month\\ period\\,\\ now\\ undergoing\\ routine\\ surveillance\\ post\\-resection\\ and\\ chemotherapy\\ for\\ a\\ cns\\ tumor\\.\ \(0\)\
\-\ tumors\\ of\\ the\\ posterior\\ fossa\\ are\\ the\\ most\\ common\\ brain\\ tumor\\ in\\ children\\.\\ \\ they\\ often\\ present\\ with\\ symptoms\\ of\\ hydrocephalus\\ \\(e\\.g\\.\\ headache\\,\\ vomiting\\ and\\ vertigo\\)\\,\\ cranial\\ nerve\\ or\\ cerebellar\\ symptoms\\ \\(e\\.g\\.\\ ataxia\\)\\.\\ \\ obstruction\\ of\\ the\\ fourth\\ ventricle\\ leading\\ to\\ hydrocephalus\\ is\\ not\\ uncommon\\.\\ \\ cerebellar\\ signs\\ may\\ be\\ unilateral\\ or\\ axial\\ depending\\ on\\ involvement\\ of\\ the\\ vermis\\ or\\ a\\ single\\ hemisphere\\.\\ \\ astrocytomas\\ and\\ medulloblastomas\\ are\\ the\\ most\\ common\\ posterior\\ fossa\\ tumors\\ in\\ children\\ and\\ present\\ with\\ similar\\ frequency\\.\\ \\ ependymomas\\ and\\ hemangioblastomas\\ are\\ also\\ commonly\\ seen\\.\ \(0\)\
\-\ astrocytomas\\ are\\ common\\ in\\ children\\ but\\ are\\ not\\ uncommon\\ in\\ adults\\.\\ \\ the\\ incidence\\ is\\ similar\\ between\\ male\\ and\\ female\\,\\ with\\ perhaps\\ a\\ slight\\ female\\ predominance\\.\\ \\ pilocytic\\ astrocytomas\\ are\\,\\ by\\ definition\\,\\ low\\-grade\\ \\(who\\ grade\\ i\\)\\ tumors\\.\\ \\ they\\ are\\ well\\ circumscribed\\ lesions\\ and\\ may\\ be\\ cystic\\,\\ solid\\ or\\ both\\.\\ \\ the\\ cystic\\ form\\ is\\ seen\\ in\\ greater\\ than\\ 75\\%\\ of\\ lesions\\ and\\ has\\ a\\ classic\\ appearance\\ of\\ a\\ mural\\ nodule\\ in\\ a\\ cyst\\.\\ \\ with\\ mri\\,\\ the\\ mural\\ tumor\\ appears\\ iso\\-\\ or\\ hypointense\\ on\\ t1\\-weighted\\ images\\ and\\ iso\\-\\ to\\ hyperintense\\ on\\ t2\\-weight\\ images\\.\\ \\ the\\ cyst\\ wall\\ does\\ not\\ consist\\ of\\ tumor\\ cells\\ and\\ thus\\ will\\ not\\ enhance\\ on\\ ct\\ or\\ mri\\.\\ \\ complete\\ resection\\ is\\ often\\ curative\\,\\ however\\ solid\\ tumors\\ may\\ not\\ be\\ as\\ amenable\\ to\\ resection\\ if\\ the\\ fourth\\ ventricle\\ is\\ involved\\.\ \(0\)\
\-\ medulloblastoma\\,\\ a\\ primitive\\ neuroectodermal\\ tumor\\,\\ is\\ rare\\ in\\ adulthood\\,\\ most\\ commonly\\ occurring\\ between\\ ages\\ 5\\ and\\ 15\\ with\\ a\\ 2\\:1\\ male\\ predominance\\.\\ \\ these\\ highly\\ malignant\\ tumors\\ usually\\ arise\\ in\\ the\\ midline\\ in\\ the\\ posterior\\ fossa\\ \\(85\\%\\)\\.\\ \\ medulloblastoma\\ appears\\ hypointense\\ on\\ t1\\,\\ hyperintense\\ on\\ t2\\ and\\ enhances\\ with\\ contrast\\.\\ \\ it\\ may\\ appear\\ well\\-circumscribed\\ but\\ is\\ often\\ found\\ to\\ be\\ invasive\\ at\\ the\\ margins\\ on\\ histology\\,\\ often\\ invades\\ the\\ fourth\\ ventricle\\ and\\ will\\ seed\\ the\\ subarachnoid\\ space\\ \\â\\€\\“\\ necessitating\\ surveillance\\ of\\ the\\ spinal\\ cord\\.\\ \\ death\\ usually\\ comes\\ within\\ months\\ if\\ not\\ treated\\.\\ \\ resection\\,\\ chemotherapy\\ and\\ radiation\\ can\\ extend\\ life\\,\\ with\\ 60\\-75\\%\\ survival\\ at\\ five\\ years\\.\ \(0\)\
\-\ hemangioblastomas\\ are\\ benign\\,\\ low\\-grade\\ \\(who\\ grade\\ i\\)\\ tumors\\ that\\ are\\ associated\\ with\\ von\\ hippel\\-lindau\\ disease\\,\\ but\\ also\\ occur\\ in\\ isolation\\.\\ \\ they\\ have\\ a\\ very\\ similar\\ appearance\\ on\\ mri\\ to\\ astrocytomas\\,\\ consisting\\ of\\ a\\ cyst\\ with\\ mural\\ module\\,\\ but\\ may\\ also\\ be\\ solid\\ or\\ multiple\\ with\\ von\\ hippel\\-lindau\\.\\ \\ the\\ mural\\ nodule\\ enhances\\ and\\ has\\ classic\\ flow\\ and\\ enhancement\\ features\\ on\\ angiography\\.\\ \\ as\\ with\\ pilocytic\\ astrocytoma\\ complete\\ resection\\ is\\ often\\ curative\\,\\ however\\ recurrence\\ is\\ not\\ uncommon\\.\ \(0\)\
\-\ ependymomas\\ most\\ commonly\\ arise\\ in\\ the\\ floor\\ of\\ the\\ fourth\\ ventricle\\.\\ \\ this\\ is\\ a\\ malignant\\ tumor\\ that\\ can\\ spread\\ throughout\\ the\\ ventricular\\ system\\.\\ \\ this\\ mass\\ can\\ be\\ differentiated\\ from\\ the\\ others\\ discussed\\ here\\ as\\ it\\ often\\ has\\ calcifications\\ on\\ ct\\.\\ \\ complete\\ resection\\ is\\ rarely\\ achievable\\,\\ but\\ these\\ are\\ usually\\ radiosensitive\\.\\ \\ on\\ mri\\,\\ ependymomas\\ may\\ appear\\ as\\ multiple\\ small\\ cysts\\ that\\ enhance\\ with\\ contrast\\.\ \(0\)\
\-\ mri\\ is\\ the\\ leading\\ diagnostic\\ and\\ surveillance\\ modality\\ for\\ posterior\\ fossa\\ tumors\\.\\ \\ it\\ provides\\ greater\\ detail\\ of\\ the\\ lesion\\ and\\ has\\ been\\ shown\\ to\\ be\\ more\\ sensitive\\ and\\ specific\\ than\\ ct\\.\\ \\ although\\ pediatric\\ patients\\ are\\ more\\ frequently\\ sedated\\ for\\ mri\\ studies\\,\\ there\\ is\\ no\\ radiation\\ and\\ no\\ iodinated\\ contrast\\ as\\ with\\ ct\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ the\\:\\ 0\\.1890192312434375\ \(0\)\
\-\ tumors\\:\\ 0\\.18756905522040168\ \(0\)\
\-\ mural\\:\\ 0\\.18607800084859075\ \(0\)\
\-\ astrocytomas\\:\\ 0\\.17423839059159565\ \(0\)\
\-\ often\\:\\ 0\\.16641381853052514\ \(0\)\
\-\ are\\:\\ 0\\.16590208674992218\ \(0\)\
\-\ and\\:\\ 0\\.16563161323305398\ \(0\)\
\-\ resection\\:\\ 0\\.1634841882128666\ \(0\)\
\-\ is\\:\\ 0\\.15964465188622004\ \(0\)\
\-\ ependymomas\\:\\ 0\\.14213412540284417\ \(0\)\
\-\ pilocytic\\:\\ 0\\.1397972835707762\ \(0\)\
\-\ fourth\\:\\ 0\\.130684810756276\ \(0\)\
\-\ curative\\:\\ 0\\.1280007728261395\ \(0\)\
\-\ on\\:\\ 0\\.12104174699936164\ \(0\)\
\-\ surveillance\\:\\ 0\\.11941603795697481\ \(0\)\
\-\ in\\:\\ 0\\.11782784805854592\ \(0\)\
\-\ fossa\\:\\ 0\\.11440900782165858\ \(0\)\
\-\ tumor\\:\\ 0\\.11434363315006674\ \(0\)\
\-\ medulloblastoma\\:\\ 0\\.11350858397204935\ \(0\)\
\-\ mri\\:\\ 0\\.11221293498834542\ \(0\)\
\-\ solid\\:\\ 0\\.11172950145069643\ \(0\)\
\-\ may\\:\\ 0\\.11000944359644971\ \(0\)\
\-\ but\\:\\ 0\\.10810101970122557\ \(0\)\
\-\ ventricle\\:\\ 0\\.10727505202139834\ \(0\)\
\-\ with\\:\\ 0\\.10701448043485326\ \(0\)\
\-\ hemangioblastomas\\:\\ 0\\.10482799415211712\ \(0\)\
\-\ grade\\:\\ 0\\.10479783588446448\ \(0\)\
\-\ be\\:\\ 0\\.10345967789826614\ \(0\)\
\-\ complete\\:\\ 0\\.10215668471705824\ \(0\)\
\-\ not\\:\\ 0\\.10068386716406648\ \(0\)\
\-\ of\\:\\ 0\\.09982053899093521\ \(0\)\
\-\ uncommon\\:\\ 0\\.09890499191335382\ \(0\)\
\-\ children\\:\\ 0\\.08955996582260599\ \(0\)\
\-\ or\\:\\ 0\\.0887239997307736\ \(0\)\
\-\ nodule\\:\\ 0\\.08627299047890939\ \(0\)\
\-\ similar\\:\\ 0\\.08330578385365889\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.08251388201635405\ \(0\)\
\-\ commonly\\:\\ 0\\.0808789818304232\ \(0\)\
\-\ predominance\\:\\ 0\\.08072219254185622\ \(0\)\
\-\ von\\:\\ 0\\.08072219254185622\ \(0\)\
\-\ they\\:\\ 0\\.07809903146392515\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.0776123691849422\ \(0\)\
\-\ most\\:\\ 0\\.07584612918944038\ \(0\)\
\-\ posterior\\:\\ 0\\.07536203982956619\ \(0\)\
\-\ as\\:\\ 0\\.0731848313555699\ \(0\)\
\-\ contrast\\:\\ 0\\.07081080195527187\ \(0\)\
\-\ will\\:\\ 0\\.07035034232608213\ \(0\)\
\-\ usually\\:\\ 0\\.06881029531001047\ \(0\)\
\-\ seen\\:\\ 0\\.0686119635712059\ \(0\)\
\-\ arise\\:\\ 0\\.06668830148181634\ \(0\)\
\-\ has\\:\\ 0\\.06656857427166063\ \(0\)\
\-\ cystic\\:\\ 0\\.06582948520743104\ \(0\)\
\-\ enhance\\:\\ 0\\.0652268009860264\ \(0\)\
\-\ leading\\:\\ 0\\.06477456975516119\ \(0\)\
\-\ enhances\\:\\ 0\\.0642309048075983\ \(0\)\
\-\ hypointense\\:\\ 0\\.06412489425607663\ \(0\)\
\-\ 75\\:\\ 0\\.06391547648164979\ \(0\)\
\-\ to\\:\\ 0\\.06375958890375065\ \(0\)\
\-\ if\\:\\ 0\\.06350776574674032\ \(0\)\
\-\ cyst\\:\\ 0\\.06305287679408446\ \(0\)\
\-\ common\\:\\ 0\\.061987327030391\ \(0\)\
\-\ recurrence\\:\\ 0\\.06016291374625776\ \(0\)\
\-\ cerebellar\\:\\ 0\\.05963215855031921\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.05948447831424806\ \(0\)\
\-\ encephalomalacic\\:\\ 0\\.05826643675977797\ \(0\)\
\-\ module\\:\\ 0\\.05826643675977797\ \(0\)\
\-\ achievable\\:\\ 0\\.05826643675977797\ \(0\)\
\-\ hyperintense\\:\\ 0\\.05796359045838028\ \(0\)\
\-\ appear\\:\\ 0\\.05739008874609121\ \(0\)\
\-\ can\\:\\ 0\\.05735875754286825\ \(0\)\
\-\ circumscribed\\:\\ 0\\.05643007297927707\ \(0\)\
\-\ it\\:\\ 0\\.055950683731875124\ \(0\)\
\-\ ct\\:\\ 0\\.0554835767957778\ \(0\)\
\-\ at\\:\\ 0\\.0550468414379595\ \(0\)\
\-\ classic\\:\\ 0\\.05450227551727251\ \(0\)\
\-\ medulloblastomas\\:\\ 0\\.053839237045698145\ \(0\)\
\-\ radiosensitive\\:\\ 0\\.053839237045698145\ \(0\)\
\-\ greater\\:\\ 0\\.053684062303131455\ \(0\)\
\-\ appears\\:\\ 0\\.053361813189544666\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.05274072289978033\ \(0\)\
\-\ malignant\\:\\ 0\\.05194338773192845\ \(0\)\
\-\ also\\:\\ 0\\.05141300393052519\ \(0\)\
\-\ seed\\:\\ 0\\.051249491229758026\ \(0\)\
\-\ isolation\\:\\ 0\\.050264915565603786\ \(0\)\
\-\ invades\\:\\ 0\\.04941203733161833\ \(0\)\
\-\ amenable\\:\\ 0\\.04865974541381791\ \(0\)\
\-\ right\\:\\ 0\\.04831796096501326\ \(0\)\
\-\ radiation\\:\\ 0\\.04828883722783797\ \(0\)\
\-\ sedated\\:\\ 0\\.047986797361978736\ \(0\)\
\-\ iodinated\\:\\ 0\\.047986797361978736\ \(0\)\
\-\ that\\:\\ 0\\.04743340783740744\ \(0\)\
\-\ necessitating\\:\\ 0\\.047378041800948054\ \(0\)\
\-\ between\\:\\ 0\\.04734653380827923\ \(0\)\
\-\ craniectomy\\:\\ 0\\.046822291515678204\ \(0\)\
\-\ suboccipital\\:\\ 0\\.045837715851523964\ \(0\)\
\-\ t1\\:\\ 0\\.04540173748857822\ \(0\)\
\-\ neuroectodermal\\:\\ 0\\.0445976221517624\ \(0\)\
\-\ appearance\\:\\ 0\\.0439296993983404\ \(0\)\
\-\ detail\\:\\ 0\\.04388721300090854\ \(0\)\
\-\ however\\:\\ 0\\.0431297353818431\ \(0\)\
\-\ recur\\:\\ 0\\.04295084208686823\ \(0\)\
\-\ adulthood\\:\\ 0\\.042666924275379825\ \(0\)\
\-\ enhancement\\:\\ 0\\.04194194034912321\ \(0\)\
\-\ t2\\:\\ 0\\.041923359693999934\ \(0\)\
\-\ perhaps\\:\\ 0\\.04188385109765411\ \(0\)\
\-\ comes\\:\\ 0\\.04188385109765411\ \(0\)\
\-\ lesions\\:\\ 0\\.04184930616403014\ \(0\)\
\-\ primitive\\:\\ 0\\.04164279988379797\ \(0\)\
\-\ consist\\:\\ 0\\.04141051613744414\ \(0\)\
\-\ than\\:\\ 0\\.04130717962775895\ \(0\)\
\-\ who\\:\\ 0\\.0412190205604966\ \(0\)\
\-\ these\\:\\ 0\\.041148928762447703\ \(0\)\
\-\ cerebellopontine\\:\\ 0\\.04076041998501771\ \(0\)\
\-\ vertigo\\:\\ 0\\.04076041998501771\ \(0\)\
\-\ vermis\\:\\ 0\\.04076041998501771\ \(0\)\
\-\ consisting\\:\\ 0\\.04055763790345868\ \(0\)\
\-\ definition\\:\\ 0\\.040170422437682575\ \(0\)\
\-\ more\\:\\ 0\\.04001269595156839\ \(0\)\
\-\ provides\\:\\ 0\\.039985276167804555\ \(0\)\
\-\ symptoms\\:\\ 0\\.03986961071779319\ \(0\)\
\-\ histology\\:\\ 0\\.03867047870331925\ \(0\)\
\-\ others\\:\\ 0\\.03838010601601867\ \(0\)\
\-\ this\\:\\ 0\\.03755848304202129\ \(0\)\
\-\ present\\:\\ 0\\.037391283412651945\ \(0\)\
\-\ ages\\:\\ 0\\.037215600169718144\ \(0\)\
\-\ originally\\:\\ 0\\.03709840240314882\ \(0\)\
\-\ floor\\:\\ 0\\.036870267470888604\ \(0\)\
\-\ occurring\\:\\ 0\\.036759184687143974\ \(0\)\
\-\ hemangioblastoma\\:\\ 0\\.036437077828716864\ \(0\)\
\-\ palsy\\:\\ 0\\.036437077828716864\ \(0\)\
\-\ discussed\\:\\ 0\\.03613043818937886\ \(0\)\
\-\ modality\\:\\ 0\\.0360314114139347\ \(0\)\
\-\ juvenile\\:\\ 0\\.03583784814428045\ \(0\)\
\-\ sensitive\\:\\ 0\\.03583784814428045\ \(0\)\
\-\ data\\:\\ 0\\.03574322272360275\ \(0\)\
\-\ incomplete\\:\\ 0\\.03574322272360275\ \(0\)\
\-\ death\\:\\ 0\\.03574322272360275\ \(0\)\
\-\ multiple\\:\\ 0\\.03564165444084041\ \(0\)\
\-\ survival\\:\\ 0\\.03555807645372473\ \(0\)\
\-\ ataxia\\:\\ 0\\.035378146271578446\ \(0\)\
\-\ well\\:\\ 0\\.03528337123540472\ \(0\)\
\-\ female\\:\\ 0\\.035162496200521275\ \(0\)\
\-\ lesion\\:\\ 0\\.03493486339642169\ \(0\)\
\-\ differentiated\\:\\ 0\\.03478554014790624\ \(0\)\
\-\ depending\\:\\ 0\\.03470519821973927\ \(0\)\
\-\ here\\:\\ 0\\.03470519821973927\ \(0\)\
\-\ frequency\\:\\ 0\\.034625854353778025\ \(0\)\
\-\ hemisphere\\:\\ 0\\.03409644265870859\ \(0\)\
\-\ cns\\:\\ 0\\.03402427127982621\ \(0\)\
\-\ adults\\:\\ 0\\.03402427127982621\ \(0\)\
\-\ images\\:\\ 0\\.03370661314119731\ \(0\)\
\-\ angiography\\:\\ 0\\.03367516258379977\ \(0\)\
\-\ 85\\:\\ 0\\.03360757360310931\ \(0\)\
\-\ extend\\:\\ 0\\.03360757360310931\ \(0\)\
\-\ cerebellum\\:\\ 0\\.0334745042259752\ \(0\)\
\-\ thus\\:\\ 0\\.0334745042259752\ \(0\)\
\-\ unilateral\\:\\ 0\\.03334415074090817\ \(0\)\
\-\ invasive\\:\\ 0\\.033153476907662634\ \(0\)\
\-\ for\\:\\ 0\\.0331289038358676\ \(0\)\
\-\ undergoing\\:\\ 0\\.033091163251717674\ \(0\)\
\-\ five\\:\\ 0\\.03290778896106381\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.03278840045563833\ \(0\)\
\-\ six\\:\\ 0\\.03272953276636585\ \(0\)\
\-\ spread\\:\\ 0\\.03272953276636585\ \(0\)\
\-\ highly\\:\\ 0\\.0326134004930132\ \(0\)\
\-\ pediatric\\:\\ 0\\.0326134004930132\ \(0\)\
\-\ rarely\\:\\ 0\\.03249934212148006\ \(0\)\
\-\ male\\:\\ 0\\.03244393686373553\ \(0\)\
\-\ noncontributory\\:\\ 0\\.03244306775680878\ \(0\)\
\-\ angle\\:\\ 0\\.031957738240824894\ \(0\)\
\-\ slight\\:\\ 0\\.03190602055685807\ \(0\)\
\-\ period\\:\\ 0\\.03185471828046008\ \(0\)\
\-\ form\\:\\ 0\\.03185471828046008\ \(0\)\
\-\ incidence\\:\\ 0\\.031363160485998735\ \(0\)\
\-\ margins\\:\\ 0\\.031085416767859652\ \(0\)\
\-\ ependymoma\\:\\ 0\\.030775946594873496\ \(0\)\
\-\ ventricular\\:\\ 0\\.03064777308152378\ \(0\)\
\-\ facial\\:\\ 0\\.030042864012071277\ \(0\)\
\-\ frequently\\:\\ 0\\.030004502941366716\ \(0\)\
\-\ life\\:\\ 0\\.029890783039883337\ \(0\)\
\-\ cranial\\:\\ 0\\.029779052510174715\ \(0\)\
\-\ features\\:\\ 0\\.02931627474091795\ \(0\)\
\-\ involved\\:\\ 0\\.029214078975543963\ \(0\)\
\-\ shown\\:\\ 0\\.028244002974989177\ \(0\)\
\-\ routine\\:\\ 0\\.028215036489638533\ \(0\)\
\-\ cells\\:\\ 0\\.028072142407400236\ \(0\)\
\-\ single\\:\\ 0\\.02801586804272896\ \(0\)\
\-\ worsening\\:\\ 0\\.02782272290008035\ \(0\)\
\-\ system\\:\\ 0\\.027795601419529754\ \(0\)\
\-\ diagnostic\\:\\ 0\\.0277685946178863\ \(0\)\
\-\ cysts\\:\\ 0\\.027608908823758087\ \(0\)\
\-\ specific\\:\\ 0\\.027608908823758087\ \(0\)\
\-\ rare\\:\\ 0\\.027504627338784685\ \(0\)\
\-\ midline\\:\\ 0\\.02740202113103209\ \(0\)\
\-\ used\\:\\ 0\\.027276038761219222\ \(0\)\
\-\ cord\\:\\ 0\\.027007325749806275\ \(0\)\
\-\ vomiting\\:\\ 0\\.026959660610141066\ \(0\)\
\-\ occur\\:\\ 0\\.02679557931720024\ \(0\)\
\-\ throughout\\:\\ 0\\.02679557931720024\ \(0\)\
\-\ studies\\:\\ 0\\.026726528924977826\ \(0\)\
\-\ calcifications\\:\\ 0\\.026590628073089366\ \(0\)\
\-\ laboratory\\:\\ 0\\.026457558695955258\ \(0\)\
\-\ involvement\\:\\ 0\\.026370361449890165\ \(0\)\
\-\ very\\:\\ 0\\.026136531377642686\ \(0\)\
\-\ nerve\\:\\ 0\\.02599206740500137\ \(0\)\
\-\ spinal\\:\\ 0\\.025870789728314064\ \(0\)\
\-\ obstruction\\:\\ 0\\.025520190187368206\ \(0\)\
\-\ signs\\:\\ 0\\.025463583325803518\ \(0\)\
\-\ does\\:\\ 0\\.025187838386924222\ \(0\)\
\-\ headache\\:\\ 0\\.02511627350296112\ \(0\)\
\-\ benign\\:\\ 0\\.025027930475320287\ \(0\)\
\-\ now\\:\\ 0\\.025010407558780687\ \(0\)\
\-\ although\\:\\ 0\\.024803798739099943\ \(0\)\
\-\ 15\\:\\ 0\\.024620104797815557\ \(0\)\
\-\ cases\\:\\ 0\\.024505900750107005\ \(0\)\
\-\ flow\\:\\ 0\\.02426784465896578\ \(0\)\
\-\ space\\:\\ 0\\.02425228533562561\ \(0\)\
\-\ no\\:\\ 0\\.023696063680246068\ \(0\)\
\-\ found\\:\\ 0\\.0235746768683498\ \(0\)\
\-\ examination\\:\\ 0\\.023314501815348748\ \(0\)\
\-\ age\\:\\ 0\\.022873837509863396\ \(0\)\
\-\ diffuse\\:\\ 0\\.0228488390471394\ \(0\)\
\-\ brain\\:\\ 0\\.022713069510315292\ \(0\)\
\-\ treated\\:\\ 0\\.022688691239985376\ \(0\)\
\-\ years\\:\\ 0\\.022333761095213966\ \(0\)\
\-\ month\\:\\ 0\\.022163428359009547\ \(0\)\
\-\ wall\\:\\ 0\\.022163428359009547\ \(0\)\
\-\ changes\\:\\ 0\\.022019394002233898\ \(0\)\
\-\ secondary\\:\\ 0\\.02159555037157221\ \(0\)\
\-\ presented\\:\\ 0\\.021246441675545766\ \(0\)\
\-\ been\\:\\ 0\\.021227057444969236\ \(0\)\
\-\ months\\:\\ 0\\.021207731865709494\ \(0\)\
\-\ axial\\:\\ 0\\.021045783317721195\ \(0\)\
\-\ patients\\:\\ 0\\.020496307197074265\ \(0\)\
\-\ both\\:\\ 0\\.02031757590729612\ \(0\)\
\-\ over\\:\\ 0\\.02025909323119928\ \(0\)\
\-\ physical\\:\\ 0\\.01975553394618749\ \(0\)\
\-\ associated\\:\\ 0\\.019203627837424016\ \(0\)\
\-\ small\\:\\ 0\\.018794058123026057\ \(0\)\
\-\ were\\:\\ 0\\.018780847985798856\ \(0\)\
\-\ have\\:\\ 0\\.018200949849184758\ \(0\)\
\-\ within\\:\\ 0\\.016780532151629675\ \(0\)\
\-\ by\\:\\ 0\\.015472132618336229\ \(0\)\
\-\ disease\\:\\ 0\\.015293840363900553\ \(0\)\
\-\ there\\:\\ 0\\.014497109648896563\ \(0\)\
\-\ from\\:\\ 0\\.014470174030389108\ \(0\)\
\-\ mass\\:\\ 0\\.013916944139393015\ \(0\)\
\-\ patient\\:\\ 0\\.011850260805098552\ \(0\)\
